Identification of the dihydrolipoamide acetyltransferase subunit of the human pyruvate dehydrogenase complex as an autoantigen in halothane hepatitis
- 1 August 1994
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 223 (3) , 1035-1047
- https://doi.org/10.1111/j.1432-1033.1994.tb19082.x
Abstract
Trifluoroacetylated (CF3CO-) proteins, elicited upon exposure of animals or humans to halothane, were recognized by anti-CF3CO antibody, monospecific for the hapten derivative N6-trifluoroacetyl-L-lysine. Anti-CF3CO antibodies cross-reacted with the dihydrolipoamide acetyltransferase (E2 subunit) of pyruvate dehydrogenase, indicating that epitopes on the E2 subunit of pyruvate dehydrogenase molecularly mimic those on CF3CO-proteins. Lipoic acid, the prosthetic group of the E2 subunit of pyruvate dehydrogenase was essential in this process, in that only the lipoylated form of the recombinantly expressed inner lipoyl domain of the human E2 subunit of pyruvate dehydrogenase, but not the unlipolyated form, was recognized by anti-CF3CO antibody. Furthermore, based on a high degree of structural relatedness, both CF3CO-Lys and (6RS)-lipoic acid, as well as the lipoylated peptide ETDK(lipoyl)ATIG specifically inhibited the recognition by anti-CF3CO antibody of the E2 subunit of pyruvate dehydrogenase, of trifluoroacetylated rabbit serum albumin and of human liver CF3CO-proteins. In sera of patients with halothane hepatitis, autoantibodies with properties identical to those of anti-CF3CO antibody were identified which could not discriminate between CF3CO-proteins and the E2 subunit of pyruvate dehydrogenase. These data suggest that the E2 subunit pyruvate of dehydrogenase is an autoantigen in halothane hepatitis and that molecular mimicry of CF3CO-proteins by the E2 subunit of pyruvate dehydrogenase is due to the similar structures of CF3CO-Lys and lipoic acid.Keywords
This publication has 57 references indexed in Scilit:
- Mechanisms of halothane toxicity: Novel insightsPharmacology & Therapeutics, 1993
- Determinant spreading and the dynamics of the autoimmune T-cell repertoireImmunology Today, 1993
- Exposure to the chlorofluorocarbon substitute 2,2-dichloro-1,1,1-trifluoroethane and the anesthetic agent halothane is associated with transient protein adduct formation in the heartBiochemical and Biophysical Research Communications, 1992
- Halothane metabolism: Kupffer cells carry and partially process trifluoroacetylated protein adductsBiochemical and Biophysical Research Communications, 1991
- Site-directed mutagenesis of lysine within the immunodominant autoepitope of PDC-E2Hepatology, 1990
- Characterisation of the reactivity of autoantibodies in primary biliary cirrhosisFEBS Letters, 1989
- Halothane hepatitis: Attempt to develop an animal modelInternational Journal of Immunopharmacology, 1987
- Antibodies to the Surface of Halothane-Altered Rabbit Hepatocytes in Patients with Severe Halothane-Associated HepatitisNew England Journal of Medicine, 1980
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970